Increased expression of adhesion molecule CD18 (LFA-1β) on the leukocytes of peripheral blood in patients with acute ischemic stroke

Acta Neurologica Scandinavica

Volumn 97, Issue 4, 1998, Pages 221-224

  Fiszer, U ^a   Korczak Kowalska, G ^b   Palasik, W ^a   Korlak, J ^a   Gorski A ^b   Czlonkowska A ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adhesion molecule; Stroke

Indexed keywords

CD18 ANTIGEN;

ARTICLE; BRAIN ISCHEMIA; CELL ADHESION; ENDOTHELIUM CELL; EXTRAVASATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKOCYTE ADHERENCE; MICROCIRCULATION; PHENOTYPE; STROKE; TISSUE INJURY;

EID: 0031942973     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1998.tb00641.x     Document Type: Article

References (24)

1. KIM JS. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996: 137: 69-78.
2. KOCHANEK PM, HALLENBECK JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992: 23: 1367-79.
3. AKOPOV SE, SIMONIAN NA, GRIGORIAN GS. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996: 27: 1739-43.
4. 2 or products of activated neutrophils. Am J Med 1991: 91: 89-94.
5. IADECOLA C. Bright and dark sides of nitric oxide in ischemic brain injury. TINS 1997: 20: 132-9.
6. ARNAOUT MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990: 75: 1037-50.
7. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Stroke 1985: 16: 885-90.
8. BAMFORD J, SANDERCOCK PAG, DENNIS M, BURN J, WARLOW CP. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991: 337: 1521-6.
9. FOULKES MA, WOLF PA, PRICE TR, MOHR JP, HIER D. The Stroke Data Bank: design, methods and baseline characteristics. Stroke 1988: 19: 547-54.
10. MIX E, FISZER U, OLSSON T et al. Vδ1 gene usage, interleukin-2 receptors, and adhesion molecules on yδ'T cells in inflammatory diseases of the nervous system. J Neuroimmunol 1994: 49: 59-66.
11. KIM SJ, CHOPP M, CHEN H, LEVINE SR, CAREY JL, WELCH KMA. Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci 1995: 128: 45-50.
12. FASSBENDER K, MOSSNER R, MOTSCH L, KISCHKA U, GRAU A, HENNERICI M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995: 26: 1361-4.
13. SHYU KOU-GI, CHANG H, LIN CHENG-CHUNG. Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol 1997: 244: 90-3.
14. FASSBENDER K, ROSSOL S, KAMMER T et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994: 122: 135-9.
15. BEAMER NB, COULL BM, CLARK WM, HAZEL JS, SILBERGER JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995: 37: 800-4.
16. TARKOWSKI E, ROSENGREN L, BLOMSTRAND CH et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke, 1995: 26: 1393-8.
17. KIM JS, SUNG SY, KIM YH et al. Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke 1996: 27: 1553-7.
18. OKADA Y, COPELAND BR, MORI E et al. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25: 202-11.
19. HESS DC, ZHAO W, CAROLL J et al. Increased expresion of ICAM-1 during reoxygenation in brain endothelial cells. Stroke 1994: 25: 1463-8.
20. MUROTA S, FUJITA H, WAKABAYASHI Y et al. Cell adhesion molecule mediates endothelial cell injury caused by activated neutrophils. Proceedings of the International Symposium "Ischemia, Cytokines and Cellular Mobilization in the Brain", Tokyo, 1996: 207-12.
21. CHOPP M, ZHANG RL, CHEN H et al. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 1994: 25: 869-76.
22. BOWES MP, ROTHLEIN R, FAGAN S et al. Monoclonal antibodies preventing leukcyte activation reduce experimental neurologic injury and enhance thrombolytic therapy. Neurology 1995: 45: 815-9.
23. ZHANG RL, CHOPP M, LI Y et al. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 1994: 44: 1747-51.
24. SHERMAN DG. The Enlimomab Acute Stroke Trial: Final Results. Neurology 1997: 48: A270.